An evaluation of 6% hydroxyethyl starch 130/0.4 use in fluid therapy following coronary artery surgery

被引:2
作者
Durukand, Ahmet Baris [1 ]
Gurbuz, Hasan Alper [1 ]
Durukan, Elif [2 ]
Salman, Nevriye [3 ]
Tavlasoglu, Murat [4 ]
Serter, Faith Tanzer [1 ]
Ucar, Halil Ibrahim [1 ]
Yorgancioglu, Cem [1 ]
机构
[1] Medicana Int Ankara Hosp, Dept Cardiovasc Surg, Ankara, Turkey
[2] Baskent Univ, Fac Med, Dept Publ Hlth, TR-06490 Ankara, Turkey
[3] Medicana Int Ankara Hosp, Dept Anesthesiol & Reanimat, Ankara, Turkey
[4] Diyarbakir Mil Hosp, Dept Cardiovasc Surg, Diyarbakir, Turkey
来源
TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2013年 / 21卷 / 02期
关键词
Cardiac surgery; crystalloid solutions; hydroxyethyl starch; POSTOPERATIVE ATRIAL-FIBRILLATION; CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; ALBUMIN; SALINE; METAANALYSIS; COAGULATION; MANAGEMENT; COLLOIDS;
D O I
10.5606/tgkdc.dergisi.2013.7256
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: This study aims to compare the effects of 6% hydroxyethylstarch 130/0.4 with a commonly used balanced electrolyte solution in patients undergoing coronary artery bypass surgery. Methods: One hundred and fifty seven patients who underwent coronary artery bypass surgery were randomized into two groups. The first group received 6% hydroxyethyl starch 130/0.4, while the second group received a commonly used balanced electrolyte solution. The effects of both solutions on postoperative outcomes were studied. Results: Six percent hydroxyethyl starch 130/0.4 did not increase postoperative blood loss and the amount of blood and blood products (p>0.05). No adverse effect was observed on renal and pulmonary functions. Intubation time, intensive care unit stay and postoperative duration of hospital stay did not differ between the groups (p>0.05). Hydroxyethyl starch had no effect on the occurrence of postoperative atrial fibrillation (p>0.05). Conclusion: Six percent hyroxyethyl starch 130/0.4 may be considered safe in fluid therapy following coronary bypass surgery.
引用
收藏
页码:276 / 283
页数:8
相关论文
共 25 条
[1]   Efficacy and Safety of Hydroxyethyl Starch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte) During Cardiac Surgery [J].
Base, Eva M. ;
Standl, Thomas ;
Lassnigg, Andrea ;
Skhirtladze, Keso ;
Jungheinrich, Cornelius ;
Gayko, Daniela ;
Hiesmayr, Michael .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2011, 25 (03) :407-414
[2]   A comparison of the hemodynamic, metabolic, renal and hemostatic effects of the use of Ringer solution and adjuvant 6% hydroxyethyl starch 130/0.4 as a pump prime solution in coronary artery bypass grafting [J].
Damar, Ertan ;
Aksun, Murat ;
Girgin, Senem ;
Goktogan, Tayfun ;
Yilmaz, Engin ;
Aran, Gulcin ;
Sencan, Atilla ;
Gurbuz, Ali ;
Karahan, Nagihan .
TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 20 (01) :22-31
[3]  
Demirok M, 2009, TURK GOGUS KALP DAMA, V17, P162
[4]   How good patient blood management leads to excellent outcomes in Jehovah's witness patients undergoing cardiac surgery [J].
Emmert, Maximilian Y. ;
Salzberg, Sacha P. ;
Theusinger, Oliver M. ;
Felix, Christian ;
Plass, Andre ;
Hoerstrup, Simon P. ;
Falk, Volkmar ;
Gruenenfelder, Juerg .
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2011, 12 (02) :183-188
[5]   Distribution of normal saline and 5% albumin infusions in cardiac surgical patients [J].
Ernest, D ;
Belzberg, AS ;
Dodek, PM .
CRITICAL CARE MEDICINE, 2001, 29 (12) :2299-2302
[6]   Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients - a randomized clinical trial [ISRCTN62699180] [J].
Harutjunyan, L ;
Holz, C ;
Rieger, A ;
Menzel, M ;
Grond, S ;
Soukup, J .
CRITICAL CARE, 2005, 9 (05) :R530-R540
[7]   Pro: Hydroxyethyl starch is preferable to albumin in the perioperative management of cardiac patients [J].
James, Michael F. M. .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2008, 22 (03) :482-484
[8]  
Jungheinrich C., 2007, Transfusion Alternatives in Transfusion Medicine, V9, P152, DOI 10.1111/j.1778-428X.2007.00070.x
[9]   Pharmacokinetics of hydroxylethyl starch [J].
Jungheinrich, C ;
Neff, TA .
CLINICAL PHARMACOKINETICS, 2005, 44 (07) :681-699
[10]   Intravascular Volume Therapy With Colloids in Cardiac Surgery [J].
Lange, Matthias ;
Ertmer, Christian ;
Van Aken, Hugo ;
Westphal, Martin .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2011, 25 (05) :847-855